共 50 条
- [41] The impact of SF3B1 mutations in CLL on the DNA-damage responseLEUKEMIA, 2015, 29 (05) : 1133 - 1142te Raa, G. D.Derks, I. A. M.Navrkalova, V.Skowronska, A.Moerland, P. D.van Laar, J.Oldreive, C.Monsuur, H.Trbusek, M.Malcikova, J.Loden, M.Geisler, C. H.Hullein, J.Jethwa, A.Zenz, T.Pospisilova, S.Stankovic, T.van Oers, M. H. J.Kater, A. P.Eldering, E.
- [42] A Murine Model Harboring Cooperating DNMT3A and SF3B1 Mutations Phenocopies SF3B1 Driven Myelodysplastic SyndromeBLOOD, 2022, 140 : 5862 - 5863Wallace, LashanaleLeal-Cervantes, AnaMetidji, AminaMyers, JacquelynRolle, ChandraTillman, HeatherObeng, Esther A.
- [43] SF3B1 Mutation Alters The Selection Of 3′ RNA Splice Sites In Chronic Lymphocytic LeukemiaBLOOD, 2013, 122 (21)Wan, YouzhongBrooks, Angela N.Wang, LiliSougnez, CarrieZhang, WandiWong, JessicaLandau, Dan-AviKotliar, DylanDeluca, DavidBrown, Jennifer R.Reed, RobinGetz, GadMeyerson, MatthewWu, Catherine J.
- [44] Low frequencies of SF3B1 mutations indicate SF3B1 inhibitor as a novel moleculartargeted drug for colorectal cancer.CANCER RESEARCH, 2013, 73 (08)Yamano, TomokiNakajima, HidenoriTsuda, SatoshiKubo, ShujiHamanaka, MieKobayashi, MasayoshiYamagishi, DaisukeKuno, TakashiTsukamoto, KiyoshiTamamoto, AstukoNoda, MasafumiMatsubara, NagahideHoon, Dave S. B.Tomita, Naohiro
- [45] SF3B1 mutations in the Driver Clone Increase the Risk of Evolution to Myelofibrosis in Patients with Myeloproliferative Neoplasms (MPN)BLOOD, 2020, 136Zhao, Lin-PierreDe Oliveira, Rafael DaltroMarcault, ClemenceSoret, JulietteGauthier, NicolasVerger, EmmanuelleMaslah, NabihRoux, BlandineParquet, NathalieDosquet, ChristineRea, DelphineZini, Jean-MarcVainchenker, WilliamRaffoux, EmmanuelGiraudier, StephaneCassinat, BrunoKiladjian, Jean-JacquesBenajiba, Lina
- [46] Mutation in SF3B1 gene promotes formation of polyploid giant cells in Leukemia cellsMedical Oncology, 39Sanjay MukherjeeAbdullah Mahmood AliVundavalli V. MurtyAzra Raza
- [47] SF3B1 mutations in patients with myelodysplastic syndromes: The mutation is stable during disease evolutionAMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (08) : E109 - E115Lin, Chien-ChinHou, Hsin-AnChou, Wen-ChienKuo, Yuan-YehWu, Shang-JuLiu, Chieh-YuChen, Chien-YuanTseng, Mei-HsuanHuang, Chi-FeiLee, Fen-YuLiu, Ming-ChihLiu, Chia-WenTang, Jih-LuhYao, MingHuang, Shang-YiHsu, Szu-ChunKo, Bor-ShengTsay, WoeiChen, Yao-ChangTien, Hwei-Fang
- [48] Incidence and Clinical Significance of SF3B1 Somatic Mutation in Chronic Lymphocytic Leukemia.BLOOD, 2012, 120 (21)Rossi, MariannaOrlandi, Ester M.Paschka, PeterZibellini, SilviaPascutto, CristianaDoehner, KonstanzeCazzola, Mario
- [49] Mutant SF3B1 promotes malignancy in PDACELIFE, 2023, 12Simmler, PatrikIoannidi, Eleonora I.Mengis, TamaraMarquart, Kim FabianoAsawa, SimranVan-Lehmann, KjongKahles, AndreThomas, TinuSchwerdel, CorneliaAceto, NicolaRatsch, GunnarStoffel, MarkusSchwank, Gerald
- [50] SF3B1: hotspot mutazionale nei prolattinomiL'Endocrinologo, 2021, 22 (3) : 281 - 282Giovanna MantovaniFederica Mangili